FdaApplication

NDA 021773

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTRAZENECA AB
application_typeNDA
approval_date2005-04-28

Products (2)

ProductActive ingredientStrengthDosage form
BYETTAEXENATIDE SYNTHETIC600MCG/2.4ML (250MCG/ML)INJECTABLE;SUBCUTANEOUS
BYETTAEXENATIDE SYNTHETIC300MCG/1.2ML (250MCG/ML)INJECTABLE;SUBCUTANEOUS

2 products